• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar for Feb. 18-22

 

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and Title Date Location Other FDA Participants Non-FDA Participants Subject
Andrew von Eschenbach, Commissioner, Food and Drugs 2/19/08 Annapolis, MD Heidi Rebello N/A Speech at the Maryland  Biz/Bio Forum on “Maryland Bioscience in the 21st Century?”
Andrew von Eschenbach, Commissioner, Food and Drugs 2/22/08 Philadelphia, PA David Acheson & Julie Zawisza N/A Speech at the Wharton Health Care Business
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer 2/18/08 through 2/22/08 N/A N/A N/A No significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs 2/18/08 through 2/22/08 N/A N/A N/A No significant meetings
Randall Lutter, Deputy Commissioner for Policy 2/18/08 through 2/22/08 N/A N/A N/A No significant meetings
Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs,  Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research 2/20/08 Washington, DC N/A Nancy Neilsen (AMA); Gail Cassel (Eli Lilly & Co) Dinner for IOM Forum on Drug Discovery, Development, and Translation
Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs,  Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research 2/21/08 Washington, DC N/A Alan Krensky (NIH); Arden Bement, Jr. (Natl. Science Foundation) How federal policy impacts medical and biological engineering (hosted by AIMBE, American Inst. for Medical and Biological Engineering)
Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs,  Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research 2/23/08 Newport News, VA N/A Nancy Davenport-Ennis (Patient Advocate Foundation); Robert Scott (Cong. Rep. VA); David Brizel (Duke Univ.) Patient Advocate Foundation Board Meeting/FDA report of progress to advocates
Margaret Glavin, Associate Commissioner, Office of Regulatory Affairs 2/18/08 through 2/22/08 N/A N/A N/A No significant meetings
Jesse Goodman, Director, Center for Biologics Evaluation and Research 2/18/08 through 2/22/08 N/A N/A N/A No significant meetings
Daniel Schultz, Director, Center for Devices and Radiological Health 2/18/08 through 2/22/08 N/A N/A N/A No significant meetings
Stephen Sundlof, Center for Food Safety and Applied Nutrition 2/18/08 through 2/22/08 N/A N/A N/A No significant meetings
Bernadette Dunham, Director, Center for Veterinary Medicine 2/20/08 Crystal City, VA N/A AHI Government Communications meeting
William Slikker, Director, National Center for Toxicological Research 2/20/08 Little Rock, AR James Kaput Richard F. Jacobs, M.D., Chairman, Dept. of Pediatrics, University of Arkansas for Medical Sciences and President, Arkansas Children's Hospital Research Institute (ACHRI) and Barry Brady, Vice President, ACHRI Discuss collaboration between ACHRI and NCTR/FDA.
William Slikker, Director, National Center for Toxicological Research 2/23/08 Oklahoma City, OK Tao Chen, Lei Guo, Huixiao Hong, Nan Mei, Leming Shi Researchers involved in bioinformatics and computational biology Presentation at the 5th Annual Conference of the MidSouth Computational Biology and Bioinformatics Society (MCBIOS 2008)
Gerald Masoudi, Chief Counsel 2/20/08 Washington, D.C. N/A FDLI Members/ Attendees FDLI Enforcement and Litigation Conference Presentation
Gerald Masoudi, Chief Counsel 2/21/08 Washington, D.C. Jeffrey Senger, OCC BIO's Biopharmaceutical Law Committee Discussion on FDAAA